- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05752292
Studera för att förstå riskinformation för att stödja och stärka (SUNRISE)
Optimera en skalbar intervention för att maximera riktlinje-rekommenderad diabetestestning efter GDM
The aim of this trial is to test components of a digital health outreach intervention to promote uptake of postpartum screening and lifestyle programs for diabetes prevention among patients with gestational diabetes (GDM). The outreach intervention, designed to be interactive and delivered online, includes standard health information plus up to four theory-based components, targeting motivational and logistical barriers to engaging in diabetes preventive care during the postpartum period. The trial leverages the Multiphase Optimization Strategy (MOST) using a randomized factorial study design.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
California
-
Pleasanton, California, Förenta staterna, 94588
- Kaiser Permanente Northern California
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Current pregnancy complicated by gestational diabetes mellitus (GDM)
- Age: 18 years and older
- Contact with the Kaiser Permanente Northern California (KPNC) Regional Perinatal Service Center
- Able to communicate in English
Exclusion Criteria:
- Diagnosis of diabetes before pregnancy
- Maternal or infant current hospitalization
- Pregnancy loss
- History of eating disorder
- Previously requested not to receive research invitations
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Faktoriell uppgift
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Condition 1
Standard health message + VA + TRI + MI+ AP |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to reflect on core personal values Interactive prompts to provide tailored information on risk factors for type 2 diabetes Interactive prompts based on principles of motivational interviewing Interactive prompts to problem solve challenges |
|
Experimentell: Condition 2
Standard health message + VA + TRI + MI |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to reflect on core personal values Interactive prompts to provide tailored information on risk factors for type 2 diabetes Interactive prompts based on principles of motivational interviewing |
|
Experimentell: Condition 3
Standard health message + VA + TRI + AP |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to reflect on core personal values Interactive prompts to provide tailored information on risk factors for type 2 diabetes Interactive prompts to problem solve challenges |
|
Experimentell: Condition 4
Standard health message + VA + TRI |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to reflect on core personal values Interactive prompts to provide tailored information on risk factors for type 2 diabetes |
|
Experimentell: Condition 5
Standard health message + VA + MI+ AP |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to reflect on core personal values Interactive prompts based on principles of motivational interviewing Interactive prompts to problem solve challenges |
|
Experimentell: Condition 6
Standard health message + VA + MI |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to reflect on core personal values Interactive prompts based on principles of motivational interviewing |
|
Experimentell: Condition 7
Standard health message + VA + AP |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to reflect on core personal values Interactive prompts to problem solve challenges |
|
Experimentell: Condition 8
Standard health message + VA |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to reflect on core personal values |
|
Experimentell: Condition 9
Standard health message + TRI + MI+ AP |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to provide tailored information on risk factors for type 2 diabetes Interactive prompts based on principles of motivational interviewing Interactive prompts to problem solve challenges |
|
Experimentell: Condition 10
Standard health message + TRI + MI |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to provide tailored information on risk factors for type 2 diabetes Interactive prompts based on principles of motivational interviewing |
|
Experimentell: Condition 11
Standard health message + TRI + AP |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to provide tailored information on risk factors for type 2 diabetes Interactive prompts to problem solve challenges |
|
Experimentell: Condition 12
Standard health message + TRI |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to provide tailored information on risk factors for type 2 diabetes |
|
Experimentell: Condition 13
Standard health message + MI+ AP |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts based on principles of motivational interviewing Interactive prompts to problem solve challenges |
|
Experimentell: Condition 14
Standard health message + MI |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts based on principles of motivational interviewing |
|
Experimentell: Condition 15
Standard health message + AP |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention Interactive prompts to problem solve challenges |
|
Experimentell: Condition 16
Standard health message |
Standard health information about postpartum screening and lifestyle programs for diabetes prevention |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Completion of recommended postpartum diabetes screening.
Tidsram: 4-12 weeks postpartum
|
Completion of a 75-gram, 2-hour oral glucose tolerance test (OGTT) |
4-12 weeks postpartum
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Completion of any recommended postpartum diabetes screening test.
Tidsram: 4-52 weeks postpartum
|
Completion of any screening test (OGTT, fasting plasma glucose, or HbA1c) |
4-52 weeks postpartum
|
|
Completion of any recommended postpartum diabetes screening test.
Tidsram: 4-12 weeks postpartum
|
Completion of any screening test (OGTT, fasting plasma glucose, or HbA1c) |
4-12 weeks postpartum
|
|
Uptake of a lifestyle program for diabetes prevention.
Tidsram: 4-52 weeks postpartum
|
Enrollment in a lifestyle program for diabetes prevention among women without type 2 diabetes mellitus according to any screening result |
4-52 weeks postpartum
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Susan D Brown, PhD, University of California, Davis
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 1826240
- R01DK122087 (U.S.S. NIH-anslag/kontrakt)
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .